Next Century Growth Investors’s Neuronetics STIM Stock Holding History

Next Century Growth Investors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-690,658	Closed	-$11.1M	–	135
2021 Q2	$11.1M	Sell	690,658 -102,047	-13%	-$1.41M	0.86%	39
2021 Q1	$9.8M	Buy	+792,705	New	+$12.2M	0.75%	46
2019 Q2	–	Sell	-136,367	Closed	-$2.08M	–	137
2019 Q1	$2.08M	Sell	136,367 -103,805	-43%	-$1.72M	0.28%	101
2018 Q4	$4.65M	Buy	240,172 +145,931	+155%	+$3.2M	0.66%	59
2018 Q3	$3.02M	Sell	94,241 -3,259	-3%	-$99.1K	0.35%	93
2018 Q2	$2.59M	Buy	+97,500	New	+$2.65M	0.33%	99

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Next Century Growth Investors's STIM Position: Q3 2021 in Review

Next Century Growth Investors sold out of Neuronetics (STIM) in Q3 2021, closing a stake of 690,658 shares — an estimated $11.1M sold.

Next Century Growth Investors first reported a position in STIM in Q2 2018 and held it in 6 quarters. The position peaked at $11.1M in Q2 2021. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

Next Century Growth Investors reported no remaining Neuronetics position as of Q3 2021 after selling out during the quarter.
Next Century Growth Investors sold 690,658 Neuronetics shares in Q3 2021, an estimated $11.1M.
Next Century Growth Investors first reported a position in Neuronetics in Q2 2018 and held it in 6 quarters.
Next Century Growth Investors's Neuronetics position peaked at $11.1M in Q2 2021.
97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Next Century Growth Investors's 13F filing for Q3 2021, filed 12 Nov 2021.